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ABSTRACT 
In  employing  fixed  frozen  ultrathin  sections  as  substrates  for  immunoferritin 
labeling of intracellular antigens, we have found that conventional glutaraldehyde 
fixation  sometimes  permits  very  little  specific  staining  of  the  sections,  either 
because it inactivates certain protein antigens, or because it renders them inacces- 
sible  to the  antibody stains.  We have developed several fixation procedures that 
are  chemically milder and allow a  uniform but less extensive cross-linking of the 
specimen.  With  these  procedures  and  precautions  in  the  handling  of the  more 
fragile frozen sections, excellent structural preservation and specific immunoferri- 
tin labeling has been achieved with several  systems. 
Immunoferritin and related specific labeling meth- 
ods  have  great  potential  in  the  electron  micro- 
scope study of the distribution of macromolecules 
in cells and cell organelles, but general application 
of the methods has required  the development of 
new procedures of specimen preparation.  In our 
technique  of  ultracryotomy  for  these  purposes 
(14),  cells  and  tissues  were  first  fixed  in  1-2% 
glutaraldehyde by standard methods and then in- 
fused  with  sucrose  or other  hydrophilic,  chemi- 
cally inert materials before freezing, which greatly 
improved the  freezing  and  the  frozen-sectioning 
characteristics of the specimens.  Ultrathin frozen 
sections were  then  recovered from the  cryobowl 
by adhering them onto a molten sucrose droplet, 
and were subsequently reacted with ferritin-anti- 
body conjugates (10,  12).  For general  purposes, 
this  technique  is still  highly satisfactory  (12,  15, 
16),  but  for immunoferritin  labeling  our experi- 
ence  of the  last  few years indicated  that  further 
refinements were necessary to increase the gener- 
ality of the method. 
The  problems  that  we  encountered,  involving 
mainly the fixation of the specimen, were of two 
kinds. (a)  1-2% glutaraldehyde, although a rela- 
tively  mild  fixative  chemically,  did  inactivate  a 
significant  number  of protein  antigens,  such  as 
bovine pancreatic trypsinogen (5) and canine kid- 
ney Na, K-ATPase (6). This is not entirely unex- 
pected,  since  reaction  of  soluble  proteins  with 
glutaraldehyde  generally  does lead to conforma- 
tional changes in  the  protein  molecules  (7).  (b) 
Even when such glutaraldehyde treatment did not 
produce a significant loss of antigenicity, however, 
we often observed much too low a level of immu- 
noferritin labeling, which we came to realize was 
an accessibility problem. Apparently, such fixation 
often  produced  a  network  of cross-bridges  that 
made a section impermeable to the relatively large 
antibody molecules  and  allowed only superficial 
labeling  of the  sections.  For  these  reasons,  we 
have investigated several alternative fixation pro- 
cedures,  together with modifications in other as- 
pects of the technique  required  to accommodate 
to them, and these are described and illustrated in 
this paper. The basic approach was to decrease the 
extent of cross-linking of the specimen, and then 
to  develop  means  to  preserve  intact  the  more 
fragile sections that resulted. 
MATERIALS AND  METHODS 
Fixation 
Aldehyde fixatives were always prepared  in 0.1  M 
phosphate buffer, pH 7.4. Formaldehyde solutions were 
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(Matheson, Coleman, and Bell, Los Angeles, Calif.)  to 
about 60~  and adding a small  amount of I  N sodium 
hydroxide. Glutaraldehyde solutions were prepared by 
diluting  50%  glutaraldehyde (Polysciences, Inc.,  War- 
rington, Pa.). Dimethylsuberimidate (DMS; refer to ref- 
erence 2), dimethyl-3,3'-dithiobispropionimidate  (DTP; 
refer to  references 11  and  17),  and  ethylacetimidate 
(EAI;  refer to  reference  18)  were synthesized in  our 
laboratory. Imidates are readily  destroyed by hydrolysis 
at  alkaline  pH,  and  their solutions must therefore be 
carefully  neutralized.  The  pH  of  dibasic  phosphate 
buffer was first raised to 10-11  by adding a small amount 
of  1-5  N  sodium hydroxide so that the  pH  was  near 
neutral,  7.2-7.6,  upon  the  addition  of the  imidates. 
Solutions were made up immediately before use. Con- 
centrations of imidates in experiments at 4~  were 6 rag/ 
ml (or about 0.02 M) in 0.1 M buffer for DMS and DTP 
and 10-12 mg/ml (or about 0.1 M) in 0.1-0.12 M buffer 
for EAI. In experiments at room temperature, the con- 
centration of DMS or DTP was raised to 12 mg/ml (or 
about 0.04 M) in 0.2 M buffer and that of EAI up to 44 
mg/ml (or about 0.4 M) in 0.5 M buffer. 
All fixation  procedures, which are described in detail 
below, were done at  4~  unless stated otherwise. For 
fixing in a low concentration of glutaraldehyde such  as 
0.2%, it is important to use a large volume of the fixative 
to maintain the concentration nearly constant. For in- 
stance, a volume of specimen which would require 5-10 
ml of 2% glutaraldehyde may be fixed in 50-100 ml of 
0.2% glutaraldehyde. It is also advisable  to agitate  the 
fixative  during  the  fixation.  These  precautions should 
also be taken for treating specimen blocks in an imidate 
solution or a mixture of an imidate and formaldehyde. In 
the present study, we used human erythrocytes and var- 
ious tissues of mouse which were dissected in fixatives to 
blocks of 1 mm or smaller widths. After fixation, these 
were  usually  kept  in  0.1  M  phosphate buffer at  4~ 
overnight, or longer, before freeze-sectioning. 
Handling of Frozen Sections 
The  general  procedure  of  ultracryotomy  was  de- 
scribed in our previous paper (14). The Sorvall MT-2B 
ultramicrotome  (DuPont  Instruments,  Sorvall  Opera- 
tions, Newton, Conn.) was used with  the LTC-2  cryo- 
attachment. In  the  present experiments, the  range  of 
temperature for sectioning was  -70 to -90~  and the 
concentration range of sucrose for the prefreezing infu- 
sion into specimens was 0.8-1.2 M in 0.1  M phosphate 
buffer, pH 7.4. 
The major problem with lightly fixed frozen sections is 
to  maintain  them  morphologically  intact  through  the 
various manipulations involved between retrieving them 
from the knife edge to the final drying on the grids. This 
problem can be solved by small changes in our previous 
procedures (14), which minimize the disruptive influence 
of  surface  tensions and  other  physical  forces.  These 
changes are as follows: (a) In retrieving frozen sections 
from the knife edge in the cryobowl to the outside, we 
had previously  used a small droplet of 2.3 M sucrose in 
an eyelash probe. We now use a droplet containing 2 M 
sucrose and 0,5-2% gelatin in 0.05 M phosphate buffer 
and employ a  1-1.5-mm loop of thin tin-plated copper 
wire to suspend the droplet, since the eyelash probe is 
inadequate to pick  up a  droplet out of the mixture of 
high viscosity. The gelatin serves to reduce the surface 
tension acting when the section melts on the liquid drop- 
let, and lightly fixed sections thereby retain their integ- 
rity.  On the other hand, for the same reasons, frozen 
sections cut in a wrinkled state tend to remain wrinkled 
when they melt on the sucrose-gelatin droplet, and care- 
ful cutting is therefore required. 
(b)  In order to wash out the sucrose, we have previ- 
ously placed the grid with the sucrose droplet face down 
on  a  buffer surface. We  now transfer the grid onto a 
series of drops containing successively lower concentra- 
tions of sucrose, each with 1-2% gelatin included. Alter- 
nately, the grid is placed directly onto a  block  of 2% 
gelatin-0.25% agarose, kept in  a  moist chamber, and 
left for 20-30 min until  the sucrose is dissolved in the 
block. The grid can then be separated from the block 
surface  by  slowly  adding  buffer to  the  surface.  Such 
measures are necessary to avoid a sudden detachment of 
the  sucrose-containing droplet which  often causes  re- 
moval of parts of fragile sections from the grid. 
(c)  In  the final  drying step before electron micro- 
scopic examination, the mechanical support for the sec- 
tions is provided by drying in 0.2-1% aqueous solution 
of a protein such as gelatin or a polysaccharide such as 
dextran, with or without an additional low concentration 
of phosphotungustic acid (PTA) or uranyl acetate (UA). 
This is to overcome the difficulty that the embedding of 
sections in  such  heavy  metal  compounds alone  often 
results in too strong a contrast for the detection of ferri- 
tin  particles.  Proteins tend  to  form  aggregates  when 
mixed  with  heavy  metal  compounds:  it  is  therefore 
advisable  to embed sections first in a protein alone and 
after drying, to negatively  stain the embedded sections 
lightly  with a  heavy metal compound. Care should be 
taken not to expose sections too long to a UA solution 
or its low pH will damage structures. An extensive OsO4 
positive  staining,  such as a few hours in a 2% solution, 
will make the sections less susceptible to damage by a 
subsequent positive  staining  with  UA or lead  citrate, 
but the increased overall  density of the sections is not 
necessarily  advantageous for the present purposes. 
lmmuno  ferritin Labeling 
The procedure to isolate human erythrocyte spectrin, 
and to prepare and purify  the rabbit anti-spectrin anti- 
body  are  described elsewhere  (9).  Rabbit  antibodies 
against  human  uterine  smooth  muscle  myosin  and 
chicken skeletal muscle myosin, prepared by similar pro- 
cedures, were gifts of Dr. J. F. Ash and Dr. Kuan Wang 
of our laboratory, respectively. Immunochemical studies 
showed that the anti-human smooth muscle myosin anti- 
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myosin but not at all with mouse skeletal muscle myosin 
and that the anti-chicken skeletal muscle myosin anti- 
body cross-reacts with mouse skeletal muscle myosin to 
some extent but not at all with mouse smooth muscle 
myosin. 
In the present study, we employed the indirect immu- 
nolabeling method in which the labeling of an antigen by 
its antibody is followed by the labeling of the antibody by 
the ferritin-goat anti-rabbit IgG conjugate. The  rabbit 
anti-spectrin antibody and the goat anti-rabbit IgG were 
affinity-chromatography-purified proteins,  while  other 
rabbit antibodies were contained in a y-globulin fraction 
of the antiserum. The conjugation of ferritin to the goat 
antibodies was done as previously described (6) or by the 
method of Kishida et al. (4). The anti-spectrin antibody 
and  the  -/-globulin  fraction  containing  anti-human 
smooth muscle myosin antibodies were used at a concen- 
tration of 0.2 mg protein/ml, while the fraction contain- 
ing antibody to chicken skeletal muscle myosin was used 
at a  concentration of  1 mg protein/ml to label mouse 
skeletal muscle myosin. The concentration of the ferri- 
tin-goat anti-rabbit IgG conjugate was 1-2 mg protein/ 
ml. 
All steps of immunoferritin labeling, except the stages 
of incubating the grids on the labeling solutions, were 
taken on 1.5-2.5 cm wide drops arranged on sheets of 
Parafilm (American Can Co., New York, N. Y.). Grids 
were  first floated  on  2%  gelatin in 0.1  M  phosphate 
buffer or 5-10% bovine serum albumin (BSA) or some- 
times on both in sequence, to condition the grid surface 
to  minimize the  level of nonspecific labeling. Directly 
from the protein solution, a grid was floated on a small 
droplet suspended on a 4-mm diam loop. This was sim- 
ply  achieved by  lifting the  loop  from  below  the  grid 
floating on the solution. The loop was either a commer- 
cially  available  one  (Ladd  Research  Industries,  Inc., 
Burlington, Vt.) or a loop made of 0.3-mm thick stain- 
less steel wire and held in an inoculating needle holder 
(VWR Sci.,  Los  Angeles, Calif.).  The  loop  was then 
turned over and after removing most but not all of the 
droplet by filter paper absorption, a droplet of the anti- 
body solution (10-20  /zl) was added from above. The 
loop was again inverted so that the grid floated on the 
top surface and was held in a moist chamber for 5-10 
min at room temperature. The grid was then transferred 
through a series of several drops of phosphate-buffered 
saline containing 0.01 M glycine, to wash unbound anti- 
bodies away. This was achieved by simply immersing the 
loop into a drop and leaving the grid on its surface. The 
grids were subsequently pooled on the surface of a large 
drop  of  the  buffer and sometimes washed  further by 
gently swirling them on  the  surface.  The  process was 
repeated  to  label the  antibodies with the  ferritin-goat 
anti-rabbit IgG conjugates. 
Sections on the grids, sometimes after a  1% glutaral- 
dehyde-10 rain post-fixation, were quickly washed on a 
distilled water surface to remove salts and dried in the 
manner described above. Observations were made in a 
Philips EM-300 electron microscope. 
RESULTS 
When intact human erythrocytes were fixed in  1- 
2%  glutaraldehyde  for  1  h, very little labeling of 
spectrin was observed (Fig.  1 a), although in vitro 
complement fixation studies (R. G. Painter and S. 
J. Singer, unpublished observation) as well as im- 
munoferritin  labeling  studies  on  erythrocyte 
ghosts  (Fig.  1 b)  indicated  that spectrin  substan- 
tially  retained  its  ability  to  bind  antibody  after 
such  treatment.  With  milder fixation such  as  15 
min  in  0.2%  glutaraldehyde  and  the  use  of  the 
improved  specimen  handling  procedures  de- 
scribed above, the erythrocyte structure remained 
intact in frozen sections, and the specific immuno- 
ferritin  labeling  of  spectrin  was  increased  more 
than 10-fold (Fig.  1 c  and d). Since this improve- 
ment is not due to any substantial difference in the 
antigen's intrinsic binding capacity, it must be due 
to  increased  accessibility  of  the  antigen  to  the 
antibody. 
While 0.2% glutaraldehyde fixation may be ad- 
equate  for  single cells  under these  conditions,  it 
does not adequately fix most tissue blocks. When 
the blocks were treated with 0.2% glutaraldehyde 
All figures (1-10) are electron micrographs of ultrathin frozen sections. Scales with and without end marks 
represent 1 and 0.1  /xm, respectively. 
lhouSE  1  (a--d) Human erythrocytes. Spectrin is only very little immunoferritin-labeled with its specific 
antibody in frozen sections of intact cells fixed in 1% glutaraldehyde for 1 h (a) but significantly in those of 
similarly fixed ghosts (b). In part (a), portions of three cells (A, B, and C) are included to show that the 
level of labeling is low regardless of the obliqueness of the section relative to  the ceil surface, which 
increases in the order from A to C. In frozen sections of intact cells fixed in 0.2% glutaraldehyde for 15 min 
(c), spectrin is extensively labeled along the cell periphery. A  control for (c), using anti-human smooth 
muscle myosin antibody followed by the ferritin-goat anti-rabbit IgG conjugate, is shown in (d). All are 
embedded in thin layers of gelatin, except (b) which is negatively stained with a mixture of 0.4% dextran 
and 0.05% PTA. All; x  80,000. 
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suitably fixed, and sections of such layers showed 
mechanical  damage  that  was  inevitably  caused 
during  the  initial dissection of fresh  tissues.  To 
overcome this difficulty, we studied the character- 
istics of formaldehyde fixation and the possibility 
of combining formaldehyde and glutaraldehyde. 
Characteristics of Formaldehyde 
Fixation 
Formaldehyde, which is apparently a chemically 
milder  fixative  than  glutaraldehyde,  allowing 
greater retention of antigenic activity of suscepti- 
ble proteins (5,  6),  is generally considered to be 
inadequate for an accurate ultrastructural preser- 
vation. Yet, a hypertonic mixture of formaldehyde 
and  glutaraldehyde was  reported to  be  a  highly 
effective  fixative,  and  it  was  surmised  that  fast 
penetrating formaldehyde may serve as a tempo- 
rary stabilizer for a  more  permanent fixation by 
glutaraldehyde (3). 
A  characteristic feature  of formaldehyde fixa- 
tion that we found distinguishes it from glutaralde- 
hyde fixation is its apparent reversibility. For in- 
stance,  a  20%  hemoglobin solution in  a  dialysis 
bag becomes quite rigid when fixed in 2% formal- 
dehyde for 1 h but subsequently returns to a fluid 
state  in  formaldehyde-free buffers  within  a  few 
hours. Similarly, erythrocytes are totally resistant 
to  lysis by  H20  treatment  immediately  after  a 
formaldehyde fixation but when  transferred into 
formaldehyde-free  buffers  begin  to  hemolyze 
within a short period of time. The duration of the 
lysis-resistant state  after the  termination of fixa- 
tion  becomes longer as the  fixation is extended, 
e.g., about 1 h after a 1-h fixation but a few hours 
after a  15-h fixation. Many tissues and cells fixed 
in 2% formaldehyde for overnight or up to a few 
days  can  in  fact  be  preserved  intact  in  frozen 
sections, when 4-8% formaldehyde is included in 
the  sucrose  solution for the  prefreezing infusion 
and if retrieved sections are immediately covered 
with gelatin. Nevertheless, formaldehyde fixation 
alone does not generally serve for the present pur- 
poses. Intact frozen sections that can be obtained 
only after such  an extensive fixation often  show 
very poor antigen accessibility. A  partial reversal 
of cross-linking, which occurs when such sections 
are exposed to buffers, causes a gain in accessibil- 
ity but inevitably also causes a  loss in structural 
delineation. 
Sequential Formaldehyde-Glutaraldehyde 
Fixation 
This partial reversibility of formaldehyde fixa- 
tion suggests that if such fixation is followed by a 
treatment  with  dilute  glutaraidehyde,  extensive 
washing should then reverse many of the remain- 
ing formaldehyde-produced cross-linkages, with- 
out  affecting the  stable glutaraldehyde-produced 
ones.  In this manner, the retention of both anti- 
genicity  and  antigen  accessibility  might  be 
achieved. This scheme  was the basis for the  fol- 
lowing fixation procedure. Tissues were dissected 
into  l-ram blocks in  1-2%  formaldehyde and in- 
cubated for 1-2 h. The hardened blocks were then 
further dissected to 0.5 mm or smaller pieces and 
fixed in 0.2% glutaraldehyde, with or without 1- 
2%  formaldehyde, for  1  h.  After the  specimens 
were  then  well  washed  in  aldehyde-free media, 
frozen sections were prepared and were immuno- 
ferritin-labeled. 
In sections of smooth muscle of mouse uterus or 
small intestine fixed in 2% glutaraldehyde for 1 h, 
smooth  muscle  myosin  can  be  immunolabeled 
with  rabbit  anti-human  uterine  myosin  but  the 
level of labeling is low (Fig. 2a and b). When the 
tissue was first fixed with 1% formaldehyde for 1 h 
and then with 0.2% glutaraladehyde for 1 h, how- 
ever, the level of labeling was markedly increased 
(Fig. 3 a). The specificity of the labeling is demon- 
strated by the observation of very low nonspecific 
labeling when normal rabbit IgG was used in place 
of the rabbit antibody (Fig. 3 b). Furthermore, in 
sections of mouse skeletal muscle, no evidence of 
labeling  with  the  anti-human  smooth  muscle 
myosin antibody was recognized (Fig. 4),  as ex- 
pected from the absence of cross-reaction between 
smooth and striated muscle myosin. 
In sections of highly contracted mouse  skeletal 
muscle, fixed with formaldehyde and glutaralde- 
hyde in the same manner  as above, a  significant 
labeling of myosin with  the  anti-chicken  skeletal 
muscle  myosin  antibody  was  recognized  in  all 
areas except on Z-lines (Fig. 5 a and b), which is in 
agreement with the  observations that the  mouse 
skeletal muscle myosin and the anti-chicken skele- 
tal muscle myosin antibody cross-react to a certain 
degree  (K.  Wang and  S. J.  Singer, unpublished 
observation). This finding also confirms that  the 
absence of labeling with the  anti-human  smooth 
muscle myosin antibody in sections of mouse skel- 
etal muscle is not due to antigen inaccessibility or 
898  THE  JOURNAL OF  CELL BIOLOGY' VOLUME 71,  1976 Fi6tn~ 2  (a and b) Mouse uterine smooth muscle, fLxed in 2% glutaraldehyde for 1 h. Immunolabeling 
of myosin using rabbit anti-human smooth muscle myosin antibody in the first stage of immunolabeling  in 
(a) is found to be significant, when compared with the control in (b) treated  with rabbit anti-human 
spectrin antibody in the first stage. S, extracellular space. Negatively stained with a mixture of 0.4% 
dextran and 0.05%  PTA. Both,  x  80,000. 
the  loss of antigenicity, but due  to  the  different 
antigenic specificity of  the  smooth  and  skeletal 
muscle myosins. 
Utilization o  f  lmidates 
Some years ago, our laboratory introduced the 
use of bifunctional imidates as fixatives for elec- 
tron microscopy (8), in a study of immunoferritin 
labeling of the hemoglobin in intact erythrocytes. 
In that case, we used diethylmalonimidate (DEM, 
refer to reference 1). Imidates are chemically even 
milder than aldehydes because, when they react 
with free amino functions on proteins, they do not 
seriously alter the ionic charge distribution on the 
protein molecule as aldehydes do (1). Bifunctional 
imidates might,  therefore,  be  expected  to  allow 
better retention of antigenic activity than glutaral- 
dehyde. On the other hand, as Hassel and Hand 
also observed (2), bifunctional imidates like DMS 
are not highly reactive near pH 7, and autolysis of 
specimens  can  occur  before  fixation.  Although 
DTP is more reactive than DMS, we have found 
that the degree of cross-linking  attained at pH 7-8 
is too low to preserve cellular structures in frozen 
sections, even after a prolonged fixation such as 8 
h. 
One might overcome this difficulty of slow reac- 
tion near pH 7 by designing other kinds of bifunc- 
tional imidates. Although loss of antigenic activity 
might  thereby  be  avoided  and  ultrastructures 
retained,  the  problem  of  antigen  accessibility 
would still have  to  be  dealt  with,  and we  have 
therefore tried other approaches. 
In particular, we have investigated the possibil- 
ity that pretreatment of a tissue block with a mono- 
functional  imidate,  followed by fixation with glu- 
taraldehyde, might serve the purpose. The mono- 
functional imidate, by converting a large fraction 
of free amino groups to unreactive amidines with- 
out cross-linking them, would restrict the  subse- 
TOKUYASU AND  SINGER Improved Procedures  for Immunoferritin Labeling  899 900  THE  JOURNAL OF  CELL BIOLOGy" VOLUME 71,  1976 FIGURE 5  (a and b) Contracted mouse skeletal muscle, fixed in  1% formaldehyde for 1 h and then in 
0.2% glutaraldehyde for 1 h. A significant labeling of myosin with the anti-chicken skeletal muscle myosin 
antibody is found in the entire area, except on Z-lines (Z).  (b) an enlarged portion of (a). Negatively 
stained with a mixture of 0.4% dextran and 0.05%  PTA. (a)  x  40,000.  (b)  x  80,000. 
quent degree of reaction and of cross-linking with 
glutaraldehyde.  We chose EAI as the monofunc- 
tional imidate in this study. 
If  erythrocytes  were  first  treated  with  0.4  M 
EAI in 0.5 M  sodium phosphate  buffer for  1 h  at 
room temperature  and  then  with  I%  glutaralde- 
hyde for 1 h  at 4~  spectrin could be specifically 
labeled at a  high level in frozen sections (Fig. 6a 
and  b).  Since  a  direct  1%  glutaraldehyde-1  h 
treatment  inhibited  the  immunoferritin  labeling 
(Fig.  ! a),  this result suggests  that  the glutaralde- 
hyde fixation was indeed significantly restricted by 
FIGURE 3  (a and b) Mouse uterine smooth muscle, fixed in 1% formaldehyde for 1 h and then in 0.2% 
glutaraldehyde for 1 h. Immunolabeling of myosin in (a) is much higher than that in Fig. 2 a. No significant 
labeling is found in the nucleus (N) or mitochondria (M). Control, treated with normal rabbit IgG in the 
first stage of immunolabeling is shown in (b). S, extracellular space. Negatively stained with a mixture of 
0.4% dextran and 0.05%  PTA. Both,  x  80,000. 
FIGURE 4  Contracted  mouse  skeletal muscle,  fixed in  1%  formaldehyde  for  1  h  and  then  in  0.2% 
glutaraldehyde for 1 h. Little labeling is seen when the first stage staining  is with the anti-human smooth 
muscle myosin antibody. Negatively stained with a mixture of 0.4% dextran and 0.05% PTA. Z, Z-lines, 
x  80,000. 
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date. 
A basic difficulty in such a procedure, however, 
is that the lack of cross-linking during the treat- 
ment with the monofunctional imidate can cause 
serious deterioration of structures in many cells 
and  tissues.  This  can  be  overcome  by  using a 
mixture of EAI and formaldehyde instead of an 
EAI  solution for  the  pretreatment.  Indeed,  in 
sections of  mouse  uterine smooth  muscle  there 
was a greater increase (fivefold or more) in immu- 
noferritin  labeling  of  myosin  when  the  tissue 
blocks were  pretreated in the mixture of 0.1  M 
EAI and 1% formaldehyde for 2 h at 4~  before 
0.2% glutaraldehyde-1 h fixation, than when the 
blocks were pretreated in 1% formaldehyde alone 
for the same period (cf.  Figs. 7-9 with Fig. 3a). 
Such  a  fixation procedure,  which  is  believed to 
provide an even milder and more uniform fixation 
than the formaldehyde-glutaraldehyde fixation, is 
quite effective in preserving cell ultrastructure in 
frozen sections (e.g., Fig. 10a--c). 
DISCUSSION 
In our experience, fixed frozen ultrathin sections 
are  generally the  most  satisfactory  preparations 
for  the  immunoferritin labeling of  intracellular 
macromolecules (10, 12) and are better than those 
prepared by our previous procedure using speci- 
mens embedded in cross-linked BSA (8, 5). How- 
ever, we have encountered a significant number of 
instances where conventional (1-2%) glutaralde- 
hyde fixation inactivates a protein antigen, or, as 
described in this paper, where it so tightly cross- 
links the intracellular matrix as to render an anti- 
gen in the thawed ultrathin frozen section inacces- 
sible to indirect immunoferritin  staining. The main 
purpose of this paper is to show that these difficul- 
ties can be  circumvented by any one  of several 
procedures which we have described. They each 
involve a first stage treatment of a specimen under 
chemically mild conditions that generally should 
preserve  antigenicity better  than  direct  fixation 
with glutaraldehyde. It is well known that formal- 
dehyde  treatment  (6)  or  reaction with  imidates 
(18, 1), as compared with glutaraldehyde, gener- 
ally have little or no effect on antigenicity of pro- 
teins. The  first stage  treatment, by modifying a 
significant fraction of available free  amino resi- 
dues, restricts the extent of modification that oc- 
curs upon the second stage treatment with glutar- 
aldehyde.  This not  only minimizes the  antigen- 
inactivating effect of glutaraldehyde, but also re- 
duces  the  extent  of  stable  cross-linking that  is 
achieved. The lesser extent of cross-linking allows 
greater  access  of  intracellular antigens to  anti- 
body. Despite the decreased cross-linking, ultra- 
structure is generally well preserved and well de- 
lineated (see  Figs.  7a  and  10).  The  apparently 
poor structural delineation at high magnifications 
is  not  a  reflection on the  technique.  Either  no 
poststaining was  employed  (Figs.  7-9),  or  only 
dilute PTA treatment, so  as to  allow maximum 
contrast between individual ferritin molecules and 
the cellular matrix. For other purposes, as desired, 
the contrast within the cellular matrix can readily 
be  increased  by  other  poststaining  procedures 
(14). 
Although  the  decreased  cross-linking renders 
the frozen ultrathin sections more fragile, the sim- 
ple precautions described above in the handling of 
such sections have allowed intense immunoferritin 
staining of several different specimens to be car- 
ded out routinely. The experience we have had so 
far  is  sufficiently diverse  to  indicate  that  these 
procedures are  of general applicability, but they 
should not be viewed as immutable prescriptions. 
For some systems, the antigen in question may not 
be adequately fixed by these procedures, and its 
translocation may not be  completely prevented; 
for other systems which are highly organized, even 
lesser  cross-linking may be  desirable.  Modifica- 
tions in the first and second stage fixation treat- 
ments may therefore  be  indicated in specific  in- 
stances. 
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